Sinopharm
1099.HK
#2008
Rank
โ‚น685.53 B
Marketcap
โ‚น219.68
Share price
0.00%
Change (1 day)
-7.61%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): โ‚น197.04 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น80.05 Billion. In 2022 the company made an earning of โ‚น279.34 Billion a decrease over its 2021 earnings that were of โ‚น284.22 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) โ‚น197.04 B-29.46%
2022 โ‚น279.34 B-1.72%
2021โ‚น284.22 B11.7%
2020โ‚น254.44 B18.44%
2019โ‚น214.82 B10.85%
2018โ‚น193.80 B3.05%
2017โ‚น188.07 B36.48%
2016โ‚น137.80 B7.11%
2015โ‚น128.65 B12.38%
2014โ‚น114.48 B25.05%
2013โ‚น91.55 B22.54%
2012โ‚น74.71 B35.43%
2011โ‚น55.16 B52.24%
2010โ‚น36.23 B30.99%
2009โ‚น27.66 B60.59%
2008โ‚น17.22 B48.29%
2007โ‚น11.61 B123.29%
2006โ‚น5.20 B